Vitamin B12 deficiency medical therapy

Revision as of 18:38, 21 September 2012 by Vishnu Vardhan Serla (talk | contribs) (Created page with "__NOTOC__ {{Vitamin B12 deficiency}} {{CMG}} ==Overview== ==Medical Therapy== [[image:6219_thumb.jpg|left|thumb|Moderate filiform taste bud atrophy thought to be due to a vita...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Vitamin B12 deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vitamin B12 deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Schilling Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vitamin B12 deficiency medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vitamin B12 deficiency medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vitamin B12 deficiency medical therapy

CDC on Vitamin B12 deficiency medical therapy

Vitamin B12 deficiency medical therapy in the news

Blogs on Vitamin B12 deficiency medical therapy

Directions to Hospitals Treating Vitamin B12 deficiency

Risk calculators and risk factors for Vitamin B12 deficiency medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Moderate filiform taste bud atrophy thought to be due to a vitamin B12, or iron deficiency‎

BTemplate:Ssub can be supplemented in healthy subjects by oral pill; sublingual pill, liquid, or strip; or by injection. BTemplate:Ssub is available singly or in combination with other supplements. BTemplate:Ssub supplements are available in forms including cyanocobalamin, hydroxocobalamin, methylcobalamin, and adenosylcobalamin (sometimes called "cobamamide" or "dibencozide").

Vitamin BTemplate:Ssub can be given as intramuscular injections of hydroxycobalamin, methylcobalamin, or cyanocobalamin. Body stores (in the liver) are refilled with half a dozen injections in the first couple of weeks and then maintenance with monthly to quarterly injections throughout the life of the patient.

BTemplate:Ssub has traditionally been given parenterally to ensure absorption in the dosage of 1 mg qd x 1 wk, then qwk x 1month, then monthly. However, oral replacement is now an accepted route, as it has become increasingly appreciated that sufficient quantities of BTemplate:Ssub are absorbed when large doses are given although this is a less efficient path for absorption (1%). This absorption does not rely on the presence of intrinsic factor or an intact ileum. Generally 1 to 2 mg daily is required as a large dose [2]. By contrast, the typical Western diet contains 5–7 µg of BTemplate:Ssub (Food and Drug Administration (FDA) Daily Value [1]). This method may be more effective than IM Rx, but requires patient compliance.

Hypokalemia, an excessive low potassium level in the blood, is anecdotally reported as a complication of vitamin BTemplate:Ssub repletion after deficiency. Excessive quantities of potassium are used by newly growing and dividing hematopoeitic cells, depleting circulating stores of the mineral.

It has been appreciated since the 1960s that deficiency can sometimes be treated with oral BTemplate:Ssub supplements when given in sufficient doses. When given in oral doses ranging from 0.1–2 mg daily, BTemplate:Ssub can be absorbed in a pathway that does not require an intact ileum or intrinsic factor. However, with the advent of sublingual and intranasal administration, tablet usage is becoming outdated. [2][3] Oral absorption is limited so regular intramuscular injections or sublingual/intranasal administration of a cobalamin (preferably methyl- or hydroxycobalamin) is necessary to restore systemic stores to physiological levels. Recent research indicates that sublingual administration eliminates a deficiency as well as injections (reference will be added) with the advantage of evading the allergy risk.

References

  1. "Dietary Supplement Fact Sheet: Vitamin B12". National Institutes of Health: Office of Dietary Supplements. Retrieved 2006-06-06.
  2. Antoinette M. Kuzminski; et al. (1998). "Effective Treatment of Cobalamin Deficiency With Oral Cobalamin". Blood. 92 (4): 1191–1198. PMID 9694707.
  3. Butler CC, Vidal-Alaball J, Cannings-John R; et al. (2006). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials". Fam Pract. 23 (3): 279–85. PMID 16585128.

Template:WH Template:WS